133 related articles for article (PubMed ID: 6697813)
41. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
42. Studies on high-dose chemotherapy of amygdalin in murine P388 lymphocytic leukaemia and P815 mast cell leukaemia.
Chitnis MP; Adwankar MK; Amonkar AJ
J Cancer Res Clin Oncol; 1985; 109(3):208-9. PubMed ID: 4008516
[TBL] [Abstract][Full Text] [Related]
43. Modulating effect of alpha-[N,N-[bis(2-hydroxyethyl)]-amino-N- (o-methoxyphenyl)-pyrrolidin-2,5-dione on the chemotherapy of murine tumours.
Ambaye RY; Indap MA; Naik SD
Cancer Lett; 1990 May; 51(2):119-25. PubMed ID: 2344589
[TBL] [Abstract][Full Text] [Related]
44. Effect of solcoseryl on antitumour action and acute toxicity of some antineoplastic drugs.
Danysz A; Sołtysiak-Pawluczuk D; Czyzewska-Szafran H; Jedrych A; Jastrzebski Z
Drugs Exp Clin Res; 1991; 17(2):133-8. PubMed ID: 1864228
[TBL] [Abstract][Full Text] [Related]
45. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M
Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
Turcotte JG; Srivastava SP; Steim JM; Calabresi P; Tibbetts LM; Chu MY
Biochim Biophys Acta; 1980 Sep; 619(3):619-31. PubMed ID: 7459369
[TBL] [Abstract][Full Text] [Related]
47. Influence of concomitant infusion of thymidine and inosine on methotrexate activity in normal and P388-bearing mice.
Uitendaal MP; Schornagel JH; Leyva A; Pinedo HM
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1527-32. PubMed ID: 6542016
[TBL] [Abstract][Full Text] [Related]
48. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
Tsuruo T; Oh-Hara T; Sudo Y; Naito M
Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
[TBL] [Abstract][Full Text] [Related]
49. Intraperitoneal injection of dipyridamole increases the life span of tumor bearing mice treated with fluorouracil.
Barberl-Heyob M; Merlin JL; Weber B
In Vivo; 1992; 6(5):535-40. PubMed ID: 1457748
[TBL] [Abstract][Full Text] [Related]
50. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
Yamauchi T; Okada K; Yoshida O
Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.
Tezuka M; Chiba Y; Okada S; Tamemasa O
J Pharmacobiodyn; 1986 Aug; 9(8):683-7. PubMed ID: 3783412
[TBL] [Abstract][Full Text] [Related]
52. [Antitumor effects of different combinations of oridonin, bleomycin A5 and nitrocaphane].
Zhang TM; Shou MG; Wang MY
Zhongguo Yao Li Xue Bao; 1986 Sep; 7(5):457-60. PubMed ID: 2438898
[No Abstract] [Full Text] [Related]
53. Methoxyphenyl maleamic acid augments the activity of cytotoxic drugs against murine tumours.
Indap MA; Ambaye RY
Indian J Cancer; 1991 Mar; 28(1):22-6. PubMed ID: 1769680
[TBL] [Abstract][Full Text] [Related]
54. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
[TBL] [Abstract][Full Text] [Related]
55. Cyclic acetal derivatives of mitomycin C.
Kaneko T; Wong H; Rose WC; Bradner WT; Doyle TW
J Antibiot (Tokyo); 1990 Jan; 43(1):122-4. PubMed ID: 2307625
[No Abstract] [Full Text] [Related]
56. [Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 leukemia].
Furuta T; Yokokura T
Gan To Kagaku Ryoho; 1991 Mar; 18(3):393-402. PubMed ID: 1900684
[TBL] [Abstract][Full Text] [Related]
57. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
Satyamoorthy K; Deshpande SS; Chitnis MP
Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
[TBL] [Abstract][Full Text] [Related]
58. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
[TBL] [Abstract][Full Text] [Related]
59. [Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center].
López-Hernández MA; de Diego Flores-Chapa J; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M
Gac Med Mex; 1998; 134(2):145-51. PubMed ID: 9618993
[TBL] [Abstract][Full Text] [Related]
60. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
